Novonesis (Novozymes) A/S (NSIS-B) - Total Assets

Latest as of March 2026: Dkr16.52 Billion DKK ≈ $2.59 Billion USD

Based on the latest financial reports, Novonesis (Novozymes) A/S (NSIS-B) holds total assets worth Dkr16.52 Billion DKK (≈ $2.59 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Novonesis (Novozymes) A/S debt service capacity to assess how comfortably operating cash covers total debt obligations.

Novonesis (Novozymes) A/S - Total Assets Trend (2002–2025)

This chart illustrates how Novonesis (Novozymes) A/S's total assets have evolved over time, based on quarterly financial data. See Novonesis (Novozymes) A/S (NSIS-B) net assets for net asset value and shareholders' equity analysis.

Novonesis (Novozymes) A/S - Asset Composition Analysis

Current Asset Composition (December 2025)

Novonesis (Novozymes) A/S's total assets of Dkr16.52 Billion consist of 12.1% current assets and 87.9% non-current assets.

Asset Category	Amount (DKK)	% of Total Assets
Cash & Equivalents	Dkr0.00	1.7%
Accounts Receivable	Dkr869.40 Million	5.3%
Inventory	Dkr772.20 Million	4.7%
Property, Plant & Equipment	Dkr0.00	0.0%
Intangible Assets	Dkr4.90 Billion	29.9%
Goodwill	Dkr6.19 Billion	37.9%

Asset Composition Trend (2002–2025)

This chart illustrates how Novonesis (Novozymes) A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NSIS-B market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Novonesis (Novozymes) A/S's current assets represent 12.1% of total assets in 2025, a decrease from 45.2% in 2002.
Cash Position: Cash and equivalents constituted 1.7% of total assets in 2025, down from 10.0% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 66.0% of total assets, an increase from 6.0% in 2002.
Asset Diversification: The largest asset category is goodwill at 37.9% of total assets.

Novonesis (Novozymes) A/S Competitors by Total Assets

Key competitors of Novonesis (Novozymes) A/S based on total assets are shown below.

Company	Country	Total Assets
Peric Special Gases Co. Ltd. A SHG:688146	China	CN¥7.26 Billion
Zhongfu Shenying Carbon Fiber Co. Ltd. A SHG:688295	China	CN¥10.25 Billion
Incitec Pivot Ltd AU:IPL	Australia	AU$8.40 Billion
Enaex S.A SN:ENAEX	Chile	CL$2.21 Billion
Dalian Bio-Chem Co Ltd SHG:603360	China	CN¥3.99 Billion
Xinxiang Richful Lube Additive Co. Ltd SHE:300910	China	CN¥5.39 Billion
New East New Materials Co Ltd SHG:603110	China	CN¥822.44 Million
Ningxia Xinri Hengli Steel Wire Rope Co Ltd SHG:600165	China	CN¥2.23 Billion

Novonesis (Novozymes) A/S - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.67	1.66	1.44
Quick Ratio	1.03	1.04	0.89
Cash Ratio	0.00	0.00	0.00
Working Capital	Dkr823.27 Million	Dkr775.70 Million	Dkr2.15 Billion

Novonesis (Novozymes) A/S - Advanced Valuation Insights

This section examines the relationship between Novonesis (Novozymes) A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.16
Latest Market Cap to Assets Ratio	1.62
Asset Growth Rate (YoY)	7.6%
Total Assets	Dkr16.35 Billion
Market Capitalization	$26.47 Billion USD

Valuation Analysis

Above Book Valuation: The market values Novonesis (Novozymes) A/S's assets above their book value (1.62x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Novonesis (Novozymes) A/S's assets grew by 7.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Novonesis (Novozymes) A/S (2002–2025)

The table below shows the annual total assets of Novonesis (Novozymes) A/S from 2002 to 2025.

Year	Total Assets	Change
2025-12-31	Dkr16.35 Billion ≈ $2.56 Billion	+7.59%
2024-12-31	Dkr15.20 Billion ≈ $2.38 Billion	-46.48%
2023-12-31	Dkr28.39 Billion ≈ $4.44 Billion	+1.46%
2022-12-31	Dkr27.98 Billion ≈ $4.38 Billion	+12.99%
2021-12-31	Dkr24.77 Billion ≈ $3.87 Billion	+20.76%
2020-12-31	Dkr20.51 Billion ≈ $3.21 Billion	+0.36%
2019-12-31	Dkr20.44 Billion ≈ $3.20 Billion	+3.76%
2018-12-31	Dkr19.70 Billion ≈ $3.08 Billion	+7.21%
2017-12-31	Dkr18.37 Billion ≈ $2.87 Billion	-1.53%
2016-12-31	Dkr18.66 Billion ≈ $2.92 Billion	+4.88%
2015-12-31	Dkr17.79 Billion ≈ $2.78 Billion	-3.45%
2014-12-31	Dkr18.43 Billion ≈ $2.88 Billion	+11.63%
2013-12-31	Dkr16.51 Billion ≈ $2.58 Billion	+9.22%
2012-12-31	Dkr15.11 Billion ≈ $2.36 Billion	+9.18%
2011-12-31	Dkr13.84 Billion ≈ $2.17 Billion	+9.92%
2010-12-31	Dkr12.59 Billion ≈ $1.97 Billion	+15.64%
2009-12-31	Dkr10.89 Billion ≈ $1.70 Billion	+9.72%
2008-12-31	Dkr9.93 Billion ≈ $1.55 Billion	+11.88%
2007-12-31	Dkr8.87 Billion ≈ $1.39 Billion	+11.37%
2006-12-31	Dkr7.96 Billion ≈ $1.25 Billion	+8.98%
2005-12-31	Dkr7.31 Billion ≈ $1.14 Billion	+2.45%
2004-12-31	Dkr7.13 Billion ≈ $1.12 Billion	-6.54%
2003-12-31	Dkr7.63 Billion ≈ $1.19 Billion	-8.59%
2002-12-31	Dkr8.35 Billion ≈ $1.31 Billion	--

About Novonesis (Novozymes) A/S

CO:NSIS-B Denmark Specialty Chemicals

Market Cap

$26.47 Billion

Dkr169.20 Billion DKK

Market Cap Rank

#1009 Global

#6 in Denmark

Share Price

Dkr410.20

Change (1 day)

-3.41%

52-Week Range

Dkr342.00 - Dkr442.80

All Time High

Dkr508.57